MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common stock and...
$3,803,498
Net cash provided by
financing activities
$3,429,286
Canceled cashflow
$374,212
Net (decrease)
increase in cash
-$2,716,857
Canceled cashflow
$3,429,286
Prepaid expenses and
other current assets
-$479,974
Amortization
$238,065
Depreciation
$160,063
Stock-based compensation
expense
$110,235
Accounts receivable
-$10,486
Accounts payable and
accrued expenses
$9,781
Payments of finance
agreement
$374,212
Net cash used in
operating activities
-$5,726,833
Canceled cashflow
$1,008,604
Net cash used in
investing activities
-$419,310
Net loss
-$6,498,167
Lease liability
-$237,270
Patent costs incurred
$231,993
Purchases of property and
equipment
$187,317
Back
Back
Cash Flow
source: myfinsight.com
Cardio Diagnostics Holdings, Inc. (CDIO)
Cardio Diagnostics Holdings, Inc. (CDIO)